XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - KRG Trust - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income (loss) $ 48,383 $ (12,154) $ (81,722)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 429,970 472,969 203,142
Gain on sales of operating properties, net (22,601) (27,069) (31,209)
Impairment charges 477 0 0
Straight-line rent (11,812) (16,632) (5,391)
Compensation expense for equity awards 10,116 10,280 6,697
Amortization of debt fair value adjustments (13,366) (13,521) (2,993)
Amortization of in-place lease assets and liabilities (12,025) (4,821) (2,611)
Changes in assets and liabilities:      
Tenant receivables (940) (16,763) (3,102)
Deferred costs and other assets (29,912) 7,522 6,857
Accounts payable, accrued expenses, deferred revenue and other liabilities (3,642) (20,528) 10,683
Net cash provided by operating activities 394,648 379,283 100,351
Cash flows from investing activities:      
Cash and restricted cash acquired in the RPAI merger 0 0 14,992
Acquisitions of interests in properties (78,274) (100,142) (10,445)
Capital expenditures (142,578) (158,540) (57,313)
Net proceeds from sales of land 3,166 4,716 54,157
Net proceeds from sales of operating properties 137,687 75,699 26,556
Investment in short-term deposits 0 125,000 (125,000)
Small business loan repayments 346 657 712
Change in construction payables (2,078) 6,341 4,413
Distribution from unconsolidated joint venture 0 1,245 1,029
Capital contribution to unconsolidated joint venture 0 (125) (134)
Net cash used in investing activities (81,731) (45,149) (91,033)
Cash flows from financing activities:      
Proceeds from issuance of common shares, net 86 30 31
Repurchases of common shares upon the vesting of restricted shares (767) (1,535) (15,031)
Purchase of capped calls 0 0 (9,800)
Debt and equity issuance costs (767) (5,159) (8,141)
Loan proceeds 369,095 455,000 215,000
Loan payments (544,410) (568,963) (77,591)
Distributions paid – common shareholders (210,546) (179,624) (57,801)
Distributions paid – redeemable noncontrolling interests (2,952) (2,622) (2,208)
Distributions to noncontrolling interests (3,196) 0 0
Acquisition of partner’s noncontrolling interest in Killingly Commons joint venture 0 (9,654) 0
Net cash (used in) provided by financing activities (393,457) (312,527) 44,459
Net change in cash, cash equivalents and restricted cash (80,540) 21,607 53,777
Cash, cash equivalents and restricted cash, beginning of year 121,970 100,363 46,586
Cash, cash equivalents and restricted cash, end of year 41,430 121,970 100,363
Supplemental disclosures      
Cash paid for interest, net of capitalized interest 120,870 113,744 59,552
Non-cash investing and financing activities      
Exchange of redeemable noncontrolling interests for common shares $ 1,568 $ 1,670 $ 4,236